U.S. Markets closed

Organovo Holdings, Inc. (ONVO)

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Add to watchlist
2.71+0.04 (+1.50%)
At close: 4:00PM EDT

2.71 0.00 (0.00%)
After hours: 4:00PM EDT

People also watch
  • Pre-market is doing well
  • From the Q&A session after the earnings call. Taylor Crouch stated that "we are holding our first conversations with some of our larger clients about how we can translate our capabilities into a routine screening program across a large number of discovery candidates and across a long period of time." Sounds promising to me. Let's see how good the Sales staff is.
  • The ER was significant for what it didn't include:no significant financial impairment other than settling former CEO's compensation, no admission of biological testing failures and no drop-off of major clients. Future direction seems set and major challenge is funding the continued growth and expansion of a ground breaking technology. Some future stock dilution is built into the price and long term investors should be rewarded in the mid to long term.
  • onvo the money pit had 400k less revenue than the previous quarter. Dilution a sure thing with those numbers.
  • Hopefully we get a president soon.
  • TOPPA ❤️ shorting ONVO.
    Cash machine 👍
    Cashmoo 👎
  • Can't believe ppl continue to think this stock is going somewhere... SAD!
  • 3-D printing holds the potential to create customized health solutions that can mean increased satisfaction and better outcomes for patients. Johnson & Johnson is working to change the landscape of healthcare through 3-D printing innovations and its affiliate Johnson & Johnson Services, Inc. recently executed a research collaboration with Inkbit Corporation, a 3-D printing startup recently spun out of MIT.
  • In my uneducated opinion, the hucksters that run onvo wanted to make $ selling dreams. They were never in it for the dubious science.
  • behind the 8 ball. onvo shareholders will wake up one day soon to find 100 other companies have passed them by. onvo had a head start on everyone and has nothing to show for it...... check out what poietis is doing, for example........
  • That was a GREAT ER. New CEO very personable, exceeded expectations
  • I like the direction this CEO is navigating the company; would like to see $10M revenue but that might be a year or 2 away. Genuinely believe once this tech is widely accepted as the NEW STANDARD - the revenue and profits will soar📈- keep up the good work, nice to see a beat on financial earnings! Excited for the call :)
  • I think she will bust over $3 tomorrow
  • There is no bottom to this frigging stock.
  • hows this for a conspiracy theory. Everyone in the san diego "lab" hangs out and tries to look busy. The "scientists" go and do their dog and pony shows, meanwhile management chips in from their monster salaries to pad "collaboration revenue". The salaries are secure because everyone wants to bet on companies who promise the moon (or a kidney)- 5 more dilutions and maybe 2 or 3 reverse splits before anyone notices. All the while, revenues steadily increasing, lIfe is grand....

    now, where did i put my tinfoil hat?
  • The timing looks perfect for $ONVO $AMMA and $NM
  • Strange turn of events in Organovo's case against George Dimitrov/Simeon Research:

    Organovo Holdings, Inc. v. Dimitrov

    Justia Opinion Summary
    Organovo Holdings, Inc. (the Company) filed suit against Georgie Dimitrov, asserting claims for, inter alia, libel, negligence, and tortious interference with prospective economic advantage. The complaint also sought an injunction. The Court of Chancery ultimately held that Dimitrov had defaulted. Before this court had entered a final order, Dimitrov entered a limited appearance and moved to vacate the default judgment, arguing that the court lacked subject matter jurisdiction over the dispute. The Court of Chancery granted the motion to vacate the default judgment, holding that the court lacked subject matter jurisdiction over the complaint because none of the complaint’s claims were equitable claims, and none of the equitable remedies that the Company cited supported the existence of jurisdiction in this court.
  • $ONVO poised to sign 100 million dollar deal soon! We will definitely be on all the radars then. Looking at the $10 range by Xmas!
  • What happened to sticking around $3? LOL